Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Pisters

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Thrombolysis|May 18, 2026
Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practiceTim A C de Vries, Joris R de Groot, Ron Pisters, et al.
The American Journal of Cardiology|September 14, 2023
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trialValeria Paradies, Matteo Maurina, Pim Tonino, et al.
Age and Ageing|April 20, 2025
Opportunistic screening for atrial fibrillation among frail older patients, little effort for a high diagnostic yield. Outcomes of the Dutch-GERAF studyLennaert A R Zwart, Jocelyn R Spruit, René W M M Jansen, et al.
Heart (British Cardiac Society)|February 4, 2014
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot studyTrang Dinh, Leo H B Baur, Ron Pisters, et al.
European Journal of Cardiovascular Nursing|July 19, 2025
Digital pulse self-measurement by a photoplethysmography smartphone application in the general population: The "#PulseDay in The Netherlands" awareness campaignDominik Linz, Jolanda Gulpen, Madelon Engels, et al.
Circulation. Cardiovascular Interventions|July 21, 2022
Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve ImplantationLia C M J Goltstein, Maxim J P Rooijakkers, Natasha C C Görtjes, et al.
Thrombosis and Haemostasis|August 19, 2016
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studiesMarcello Di Nisio, Maria C Vedovati, Antoni Riera-Mestre, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
Journal of Cardiac Failure|June 15, 2022
Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP StudyJob J Herrmann, Fabienne Beckers-Wesche, Lisette E H J M Baltussen, et al.
European Journal of Heart Failure|August 14, 2025
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HFJishnu Malgie, Mariëlle I Wilde, Stefan Koudstaal, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Thrombolysis|May 18, 2026
Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practiceTim A C de Vries, Joris R de Groot, Ron Pisters, et al.
The American Journal of Cardiology|September 14, 2023
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trialValeria Paradies, Matteo Maurina, Pim Tonino, et al.
Age and Ageing|April 20, 2025
Opportunistic screening for atrial fibrillation among frail older patients, little effort for a high diagnostic yield. Outcomes of the Dutch-GERAF studyLennaert A R Zwart, Jocelyn R Spruit, René W M M Jansen, et al.
Heart (British Cardiac Society)|February 4, 2014
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot studyTrang Dinh, Leo H B Baur, Ron Pisters, et al.
European Journal of Cardiovascular Nursing|July 19, 2025
Digital pulse self-measurement by a photoplethysmography smartphone application in the general population: The "#PulseDay in The Netherlands" awareness campaignDominik Linz, Jolanda Gulpen, Madelon Engels, et al.
Circulation. Cardiovascular Interventions|July 21, 2022
Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve ImplantationLia C M J Goltstein, Maxim J P Rooijakkers, Natasha C C Görtjes, et al.
Thrombosis and Haemostasis|August 19, 2016
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studiesMarcello Di Nisio, Maria C Vedovati, Antoni Riera-Mestre, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
Journal of Cardiac Failure|June 15, 2022
Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP StudyJob J Herrmann, Fabienne Beckers-Wesche, Lisette E H J M Baltussen, et al.
European Journal of Heart Failure|August 14, 2025
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HFJishnu Malgie, Mariëlle I Wilde, Stefan Koudstaal, et al.
Pageof 8